Document is current

Article History

Accepted: 18 April 2025

First Online: 10 May 2025

Declarations

:

: Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement. Under the direction of the authors, Trina Soluta and Claire Cartledge of CMC Affinity, a division of IPG Health Medical Communications, provided medical writing and editorial support, respectively, which was funded by Jazz Pharmaceuticals in accordance with Good Publication Practice (GPP 2022) guidelines. Jazz Pharmaceuticals reviewed the manuscript for factual accuracy. Although Jazz Pharmaceuticals was involved in the review of the manuscript, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication in Drugs was made by the authors independently.

: L. Pagano is a board member of Basilea, Cidara Therapeutics, Gilead Sciences, Janssen, Jazz Pharmaceuticals, MSD, Novartis, Pfizer, and Stemline Therapeutics; a consultant for Cidara Therapeutics and Stemline Therapeutics; and has been a speaker for Astellas Pharma, Gilead Sciences, Janssen, Jazz Pharmaceuticals, Kyowa Kirin, MSD, Novartis, and Pfizer. R. Danesi has received speaker’s bureau/advisor's fees from AstraZeneca, EUSA Pharma, Genzyme, Gilead Sciences, Ipsen, Janssen, Jazz Pharmaceuticals, Lilly, Novartis, Pfizer, and Sanofi. E. Benedetti has received speaker’s bureau/advisor’s fees from AstraZeneca, BeiGene, and Jazz Pharmaceuticals. R. Morgagni has no conflicts of interest to declare. L. Romani has no conflicts of interest to declare. A. Venditti has received research funding from Jazz Pharmaceuticals; he was a consultant for AbbVie, Amgen, Astellas Pharma, Astex Pharmaceuticals, AstraZeneca, Bristol Myers Squibb, Delbert Pharma, Glycostem, Janssen, Kite-Gilead, Menarini, Novartis, Otsuka, Pfizer, Servier, and Stemline Therapeutics. All are not related to this manuscript.

: All authors were involved in study concept and design and have contributed to discussions around the manuscript content. All authors critically reviewed the manuscript and approved the final version for submission. All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article and take responsibility for the integrity of the work.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.